 Sentinel node location and biopsy
专利摘要:
A method and apparatus for locating and accessing a patient's sentinel lymph nodes which are associated with a lesion site of the patient. A radiopharmaceutical is injected at or near a lesion site within a patient's body. The migration of the radiopharmaceutical and accumulation of the radiopharmaceutical in a sentinel node of the patient is monitored with a gamma camera or radiation energy detector from outside the patient's body. The sentinel node can then be accessed with a cannula having an RF energy electrode on the distal end of the cannula which is activated during insertion of the cannula. Once the distal end of the cannula is positioned adjacent the sentinel node, a radiation energy detector can be inserted through the cannula to verify the proximity of the distal end of the cannula to the sentinel node. Once the precise position of the sentinel node is verified, the radiation energy detector is withdrawn from the cannula and an anchor device inserted through the cannula and the distal end of the anchor device then positioned in the sentinel node. The distal end of the anchor device is then secured to the sentinel node and used as a locator for subsequent procedures which may include surgical or other noninvasive removal of the sentinel lymph node. 公开号:US20010002250A1 申请号:US09/727,112 申请日:2000-11-29 公开日:2001-05-31 发明作者:Fred Burbank；Paul Lubock 申请人:SenoRx Inc； IPC主号:A61B10-0266
专利说明:
[0001] This application is a continuation in part of copending U.S. patent application Ser. No. 09/146,185, filed Sep. 1, 1998, by Burbank et al., U.S. patent application Ser. No. 09/159,467, filed Sep. 23, 1998, by Burbank et al.; U.S. patent application Ser. No. 09/856,187, filed Jul. 16, 1999 by Burbank et al.; and U.S. patent application Ser. No. 09/477,255, filed Jan. 4, 2000 by Burbank et al. All of the above copending applications are incorporated by reference herein in their entirety. [0001] BACKGROUND OF THE INVENTION [0002] The invention relates to the field of medical devices and methods used in the treatment of diseases such as cancer which have the ability to metastasize within a patient's body. More specifically, the invention is directed to methods and devices for locating sentinel lymph nodes associated with a lesion site within a patient's body so that the sentinel lymph nodes may thereafter be selectively removed and analyzed to determine whether disease has spread from the primary lesion site to the sentinel lymph nodes. In the case of breast cancer patients, such methods and devices may eliminate the need for complete axillary lymph node dissection in patients who do not require such invasive and debilitating procedures. [0002] [0003] With regard to breast cancer patients specifically, the determination of the severity of the disease or staging is frequently determined by the level of lymph node involvement in those lymph nodes which correspond to the primary cancer lesion site in the breast. The lymph nodes which correspond to the breast area are typically located in the armpit or axilla of the patient and are connected to the breast tissue of the patient by a series of lymph ducts. Other likely areas for sentinel nodes include inframammary and submammary locations and elsewhere in the patient's chest. The sentinel lymph nodes can be in fluid communication with other surrounding lymph nodes, however, lymph drainage from the lesion site will first flow to the sentinel lymph nodes. Thereafter, lymph fluid drainage may then continue on to lymph nodes surrounding the sentinel nodes. [0003] [0004] Studies have shown that by the time a typical breast cancer lesion reaches the size of 1-2 cm, the cancer will have metastasized to at least one of the sentinel lymph nodes in about one third of patients. Malignant cells break off and drain through the lymph fluid ducts to the lymph nodes and will be apparent in excised lymph nodes if the malignant cells embed in the lymph node. In patients with more advanced disease, the likelihood of spread to sentinel nodes is higher as is the likelihood of spread of the disease to the lymph nodes surrounding the sentinel lymph nodes. [0004] [0005] As discussed above, when a tumor lesion is under 1-2 cm, only about ⅓of patients will have cancer cells in the corresponding lymph nodes, and in the patients where the disease has spread to the lymph nodes, it is often confined to the sentinel lymph nodes. [0005] [0006] In the past, a breast cancer patient would normally have a complete axillary lymph node dissection as an adjunct to removal of the primary lesion in the breast. Thus, the patient's entire lymph node system in the armpit area is removed and biopsied to determine the stage of the cancer and what further treatment was required. However, as discussed above, when the lesion is under 1-2 cm, two thirds of the patients had no migration of cancer cells to the lymph nodes at all, and in others, cancer had only migrated to the sentinel lymph nodes. Thus, total axillary lymph node dissection in two-thirds of the cases were unnecessary. It should be noted that total axillary lymph node dissection can be an extremely painful and debilitating procedure for patients who often suffer from severe lymph edema as a result of the body's inability to channel the flow of lymph fluid once most or all of the lymph nodes have been excised. [0006] [0007] Thus there is a need for methods and devices that can be used to determine the location of sentinel lymph nodes corresponding to a patient's primary lesion site, and a reliable and noninvasive means of accessing the sentinel lymph nodes to determine whether they are involved in the disease. If the sentinel lymph nodes are determined not to have cancer cells within them, then a total axillary lymph node dissection may be avoided. [0007] [0008] It has been known to use radioactive materials or radiopharmaceuticals as localizing agents which can be injected into the area of a primary lesion to monitor the flow of the materials within the patients body using a variety of detectors. Radioactive material such as Technetium 99 m, Indium 111, Iodine 123 or Iodine 125 can be injected in a fluid into the site of a primary lesion and the migration of the radioactive material through lymph ducts to the patient's corresponding sentinel lymph nodes and other surrounding lymph nodes monitored. Although techniques exist to locate the sentinel lymph nodes of a patient with such radiopharmaceutical tagging, what has been needed are methods and devices to precisely locate and access the sentinel lymph nodes of the patient in a noninvasive manner so as to minimize trauma to the patient should it be determined that a total axillary node dissection is unnecessary. [0008] SUMMARY OF THE INVENTION [0009] The invention is directed generally to a method and system for locating and/or accessing specific target sites within the body of a patient. More specifically, the invention is directed to a method and system for locating and accessing a sentinel lymph node of a patient which corresponds to a lesion site within the patient's body. [0009] [0010] In one embodiment of the invention, a radioactive material is injected into a patient's body near a primary lesion site or other site of interest within the patient. The approximate position of a sentinel lymph node is within the patient's body is determined by detecting radiation from the radioactive material accumulated within the sentinel lymph node with a radiation detector external to the patient's body. The sentinel lymph node can then be accessed with a cannula having an RF electrode disposed on a distal end of the cannula by activating the RF electrode to ablate tissue while passing the cannula into the patient's body until the distal end of the cannula is disposed adjacent the sentinel lymph node. Thus, access to a patient's sentinel lymph node corresponding to a lesion site is achieved with minimal trauma to the patient, requiring only a hypodermic injection at the lesion site and a channel through the patient's tissue from the outside surface of the skin to the sentinel node, the channel being no larger than the outside dimension of the cannula. [0010] [0011] Once the distal end of the cannula is positioned adjacent the sentinel lymph node, an anchor device can be inserted through the cannula and into the sentinel lymph node. The distal end of the anchor device can then be secured to the sentinel lymph node. Once the distal end of the anchor device is secured to the lymph node, the patient can be transferred to a surgical suite and the lymph node surgically removed with the anchor device attached thereto. The anchor device is thus used as a locator for the sentinel lymph node during the surgical procedure. [0011] [0012] In some embodiments of a method of the invention, a gamma camera is used to determine the approximate position of the sentinel lymph node within the patient's body prior to accessing the sentinel lymph node with the cannula assembly. Alternatively, a hand held radiation detecting wand or the like can be used to determine the approximate position of the sentinel lymph node within the patient's body. Once the approximate position of a sentinel lymph node is known, the skin of the patient can be marked with a visible mark above the location of the sentinel lymph node prior to accessing the sentinel lymph node with the cannula. [0012] [0013] A cannula suitable for use with the method discussed above can have an outer hollow shaft having an inner lumen slidingly disposed about an inner shaft having an RF electrode disposed on the distal end of the inner shaft. The inner shaft can be withdrawn from the outer hollow shaft prior to insertion of the anchor device through the inner lumen of the outer hollow shaft to access a sentinel lymph node. The RF electrode can be an arcuate shaped wire spaced distally from a distal extremity of the distal end of the cannula whereby tissue is ablated along the length of the RF electrode and displaced by the distal end of the cannula as it is advanced through the tissue. Often it is desirable to image the cannula and sentinel lymph node with an ultrasound imaging system during insertion of the cannula into the patient's body. [0013] [0014] The proximity of the distal end of the cannula to a radioactive or “hot” sentinel lymph node can be determined by inserting a radiation energy detector probe through the inner lumen of the hollow outer shaft of the cannula and detecting an amount of radiation energy emanating from the tissue along the longitudinal axis of the hollow outer shaft. The hollow outer shaft or the radiation energy detector within the outer hollow shaft can be manipulated while in the patient to detect the amount of radiation energy emanating from various portions of the tissue as they pass in front of the distal end of the radiation energy detector during the manipulation. [0014] [0015] The relative amount of radiation detected from the various portions of tissue adjacent the longitudinal axis of the hollow outer shaft can be compared by a visual or audio signal or the like in order for the operator of the system to determine the position of the radiation energy detector where the maximum signal strength exists. The input of the radiation energy detector can be configured so as to maximize output signal strength when a hot sentinel lymph node is disposed directly distal of the distal end of the radiation energy detector. Thus, by maximizing the output signal, the operator can determine the precise location of a hot sentinel lymph node. [0015] [0016] Once it is confirmed that the distal end of the outer hollow shaft of the cannula is disposed adjacent a hot sentinel node, the distal end of an anchor device can be inserted through the inner lumen of the outer hollow shaft and secured to the sentinel lymph node. The anchor device can be secured to the sentinel node by deploying at least one extension wire from the distal end of the anchor device into the sentinel lymph node. In addition, an outer extremity of the extension wires can be configured to emit RF energy during deployment of the extension wire so as to ablate tissue adjacent a distal end of the extension wire as it is being advanced through tissue during deployment. Ablation energy activation of the distal ends of the extension wires facilitates penetration of tissue during deployment of the extension wires. [0016] [0017] An embodiment of an anchor device for locating a desired portion of tissue within a patient can have an elongate shaft with a proximal and distal end. At least one extension wire is disposed at the distal end of the elongate shaft having a withdrawn configuration and a deployed configuration extending from the distal end of the shaft. The anchor device may also include a deployment actuator disposed proximal of the distal end of the elongate shaft and configured to deploy the extension wire from a retracted configuration to an extended configuration. The deployment actuator of the anchor device can be configured to both extend the extension wires and activate RF energy to the extension wires. One embodiment of an anchor device may have markings spaced at predetermined intervals to delineate the diameter of extension of the extension wires. [0017] [0018] In one embodiment of an anchor device, an RF electrode is disposed on the distal end of the elongate shaft configured to ablate and penetrate tissue in a manner similar to the RF electrode on the distal end of the cannula discussed above. An RF electrode on the distal end of the elongate shaft can be in the form of an arcuate wire spaced distally from the distal extremity of the distal end of the elongate shaft and optionally may lie in substantially the same plane as the longitudinal axis of the elongate shaft. [0018] [0019] A radiation energy detector for locating the position of radioactive tissue within the body of a patient suitable for use with the methods discussed above can be an elongate shaft having a proximal end, a distal end and an outer transverse dimension of the distal end of up to about 4 mm. A detector body is disposed at the distal end of the elongate shaft which is collimated to receive radiation energy at an angle of up to about 30°, preferably about 10° to about 20° from a longitudinal axis of the elongate shaft. A detector body signal processor is coupled to the detector body. A handle assembly can be disposed at the proximal end of the elongate shaft of the radiation energy detector. The length of the elongate shaft is typically configured to access to a patient's tissue through an inner lumen of a cannula and can be about 5 to about 15 cm. [0019] [0020] The detector body signal processor can be configured to emit an audible signal to a user of the detector which has an amplitude which increases logarithmically in relation to an increase in the amount of radiation energy being detected. Alternatively, the detector body signal processor can produce a visual signal to a user of the detector which is proportional in amplitude to the amount of radiation energy being detected. [0020] [0021] These and other advantages of the invention will become more apparent from the following detailed description when taken in conjunction with the accompanying exemplary drawings. [0021] BRIEF DESCRIPTION OF THE DRAWINGS [0022] FIG. 1 is a diagrammatic view of a patient being injected with a radioactive material including monitoring of migration of the radioactive material from a lesion site to a sentinel node with a hand held radiation energy detector and a gamma camera. [0022] [0023] FIG. 2 is a diagrammatic view of a medical procedure having features of the invention including ultrasonic imaging of insertion of a cannula with an RF electrode disposed on the distal end of the cannula. [0023] [0024] FIG. 3 is a perspective view of a cannula with a two element RF electrode disposed on the distal end of the cannula with the RF electrode in an expanded state. [0024] [0025] FIG. 4 is an elevational view in partial longitudinal section of a cannula with a two element RF electrode on the distal end in an expanded state. [0025] [0026] FIG. 5 is an elevational view in partial longitudinal section of the cannula of FIG. 4 with the distal end of the inner shaft retracted into a hollow outer shaft and the RF electrode in a contracted state within the hollow outer shaft. [0026] [0027] FIG. 6 is a schematic view of an outer hollow shaft of a cannula disposed within a patient with the inner shaft of the cannula withdrawn and the distal end of the outer hollow shaft adjacent a sentinel lymph node. A radiation energy detector probe is positioned for insertion into the outer hollow shaft of the cannula. [0027] [0028] FIG. 7 is an elevational view in partial section of a radiation energy detector disposed within an outer hollow shaft of a cannula with the distal end of the radiation energy detector probe disposed adjacent a first sentinel lymph node and a second sentinel lymph node with the longitudinal axis of the outer hollow shaft and radiation energy detector probe substantially aligned with the center of the first sentinel lymph node. [0028] [0029] FIG. 8 is a diagrammatic view of the distal end of a radiation energy detector probe disposed adjacent a first and second sentinel lymph node with the longitudinal axis of the detector probe substantially aligned with the center of the first sentinel lymph node and a phantom outline of the distal end of the radiation energy detector probe wherein the longitudinal axis thereof is substantially aligned with the center of the second sentinel lymph node. [0029] [0030] FIG. 9 is a perspective view of an anchor device having features of the invention. [0030] [0031] FIG. 10 is an elevational view in partial longitudinal section of an anchor device having features of the invention, wherein the extension wires at the distal end of the anchor device are in a retracted position. [0031] [0032] FIG. 11 is an elevational view in partial section of the anchor device of FIG. 10 with the extension wires in an expanded position extending radially outward from a longitudinal axis of the anchor device. [0032] [0033] FIG. 12 is a transverse cross sectional view of a handle assembly of the anchor device of FIG. 11 taken along lines [0033] 12-12 of FIG. 11. [0034] FIG. 13 is a transverse cross sectional view of the elongate shaft of the anchor device of FIG. 11 taken along lines [0034] 13-13 in FIG. 11. [0035] FIG. 14 is an end view in partial transverse cross section of the distal end of the anchor device of FIG. 11 taken along lines [0035] 14-14 of FIG. 11. [0036] FIG. 15 is a top view of the actuator switch of the anchor device of FIG. 11 in a fully forward distal position corresponding to full extension of the extension wires in an outward radial direction. [0036] [0037] FIG. 16 is a schematic view of an anchor device being inserted into an outer hollow shaft of a cannula the distal end of which is disposed adjacent a sentinel lymph node. [0037] [0038] FIG. 17 is an enlarged view in partial longitudinal section of the anchor device of FIG. 16 wherein the distal end of the anchor device is disposed within a sentinel lymph node of the patient with the extension wires in a retracted position. [0038] [0039] FIG. 18 is an enlarged view in partial section of the anchor device of FIG. 16 wherein the distal end of the anchor device is disposed within a sentinel lymph node of the patient with the extension wires in an extended position wherein the extension wires have pierced and are mechanically secured to the sentinel lymph node. [0039] [0040] FIG. 19 is a schematic view of an outer hollow shaft of a cannula and a handle assembly of an anchor device being removed from the patient proximally with the distal shaft of the anchor device remaining within the patient with the distal end of the anchor device secured to the sentinel lymph node with the extension wires. [0040] [0041] FIG. 20 is an elevational view in partial section of an anchor device having features of the invention including extension wires which are radially extendable from the distal end of the anchor device, an expandable RF electrode on the distal end of the anchor device and a radiation detector probe disposed within an inner lumen of the anchor device and which is optionally axially moveable within the inner lumen of the anchor device. [0041] DETAILED DESCRIPTION OF THE INVENTION [0042] FIG. 1 illustrates a patient [0042] 10 being injected with a radioactive material or radiopharmaceutical via a syringe 11 having a hypodermic needle 12 at a lesion site 13 within the patient's breast 14. Monitoring of migration of the radiopharmaceutical 15 from the injection location 16 in or near the lesion site 16 to a sentinel node 17 is carried out with a hand held radiation energy detector 21 or alternatively a gamma camera 22. The approximate position of the sentinel lymph node 17 is determined by detecting radiation from the radioactive material 15 accumulated within the sentinel lymph node 17 with the hand held radiation detector 21 or the gamma camera 22. Radioactive material 15 such as Technetium 99 m, Indium 111, Iodine 123 or Iodine 125 can be injected in a fluid into the site of a primary lesion 13 and the migration of the radioactive material through lymph ducts to the patient's corresponding sentinel lymph nodes 17 and other surrounding lymph nodes observed. [0043] By correctly timing the observation of the radiation energy signals coming from the patient's body after injection of the radioactive substance [0043] 15, it is possible to locate the sentinel lymph nodes 17 corresponding to the lesion site 13. The sentinel lymph nodes 17 corresponding to a given lesion site 13 or other site of interest within a patient's body are those lymph nodes to which lymph fluid emanating from the lesion site drains to first. As discussed above, the lymph nodes which correspond to the breast area are typically located in the armpit of the patient and are connected to the breast tissue 14 of the patient 10 by a series of lymph ducts. Lymph nodes of the axilla are approximately 1 to 2 cm in diameter and are approximately 1 to 5 inches deep in the tissue of the armpit area. [0044] The sentinel lymph nodes [0044] 17 can be in fluid communication with other surrounding lymph nodes, however, lymph drainage from the lesion site 13 will first flow to the sentinel lymph nodes 17. Thereafter, lymph fluid drainage may then continue on to lymph nodes surrounding the sentinel nodes 13. Therefore, if a patient 10 is monitored or observed with a hand held radiation detector 21 or gamma camera 22 after the radioactive material 15 has migrated through the lymph ducts to the sentinel lymph nodes 17 but prior to dispersion of the radioactive material to the lymph nodes surrounding the sentinel nodes, an accumulation of radioactive material 15 will be observed in the sentinel lymph nodes 17. These hot sentinel nodes 17 will be clearly distinguishable from surrounding non-radioactive lymph nodes using radiation energy detectors from outside the patient's body 10, thus indicating an approximate position of nodes 17 in a non-invasive manner. [0045] The hand held radiation energy detector [0045] 21 has a hand held probe 23 with a proximal end 24 and a distal end 25, a control and display unit 26, and an electrical conduit or cable 27 disposed between the control unit 26 and the hand held probe 23. The control unit 26 can produce an audible or visual output that is commensurate with the amplitude of radiation energy signal being received at the distal end 25 of the hand held probe 23. Typically, the hand held probe 23 will only detect radiation energy which impinges in a proximal direction upon the distal end 25 of the hand held probe 23 at some predetermined angle with respect to a longitudinal axis 31 of the hand held probe 23. Thus, by manipulating the location and direction of the distal end 25 of the hand held probe 23, the approximate location of the hot sentinel lymph nodes 17 within the patient 10 can be determined by maximizing the audio or visual signal generated by the control and display unit 26. [0046] The gamma camera [0046] 22 shown in FIG. 1 has a receiver unit 33, a control unit 34 and a display 35. Radiation energy emitted from the radioactive material 15 injected into the patient 10 travels through the tissue of the patient 10 to the receiver unit 33 which then generates and electrical signal at a location corresponding to the location of the radioactive material source in the patient 10. The signal or hits from the radiation energy which impinges on the receiver 33 can be accumulated or stored such that the display 35 will show all hits received from the various portions of the receiver 33. In this way, the relative location of radioactive material 15 in the patient's body 10 can be seen on the display and particularly locations in the patient's body 10 where radioactive material 15 has accumulated. The skin of the patient 10 can be marked with a visible mark above the location of the sentinel lymph node 17 to indicate the approximate position of the sentinel node 17 for future reference during the procedure. [0047] Once the approximate position of the sentinel lymph nodes [0047] 17 of a patient 10 corresponding to a primary lesion site 13 is determined, an access device 36 may be used to breach tissue over the lymph nodes. This allows locating the sentinel nodes 17 with greater precision. FIG. 2 shows ultrasonic imaging of insertion of an access device 36 consisting of a cannula 37 having an RF electrode 41 disposed on the distal end 42 of the cannula 37, an RF energy generator 43 in electrical communication with the RF electrode 41, a cannula handle assembly 44 at a proximal end 45 of the cannula 37 and a ground pad 46 secured to and in electrical communication with the patient's body 10 and the RF generator 43. The sentinel lymph node 17 is accessed by passing the cannula 37 with the RF electrode 41 energized to emit RF energy therefrom into the patient's body 10 until the distal end 42 of the cannula 37 is disposed adjacent the sentinel lymph node 17. [0048] The RF generator [0048] 43 for the RF electrode 41 can be any of a variety of standard electrosurgical units generating radiofrequency energy in a range of about 300 to about 6,000 kHz, specifically, about 350 to about 1,000 kHz. Power output for the RF generator 43 can be about 25 to about 150 watts, preferably about 75 to about 125 watts. The RF electrode 41 can be made of a variety of materials, including stainless steel, tungsten, nitinol and the like. The RF electrode material may have a cross section that is round, rectangular, oval or any other suitable configuration and generally has a transverse dimension of about 0.001 to about 0.015 inch, specifically about 0.006 to about 0.010 inch. [0049] Because large arteries and nerves are generally located in the same area as the axillary lymph nodes of a patient [0049] 10 and could be compromised without an accurate and noninvasive access device 36, ultrasonic imaging can be used while the cannula 37 is being inserted into the patient 10. An ultrasonic imaging system 47 having a transducer 51, transducer cable 52, control unit 53 and display 54 is shown in FIG. 2. The two sentinel lymph nodes 17 are imaged on the display 54. The relative location of the target sentinel lymph node 17 and cannula 37 can be imaged and monitored during insertion of the cannula 37 to ensure accurate placement of the cannula and avoidance of sensitive anatomical features such as nerves and arteries. Because RF tissue ablation frequently interferes with ultrasonic imaging and the like, it may be desirable to use a system for reduction of such interference such as is taught by copending U.S. patent application Ser. No. 09/527,868, by Dabney et al., filed Mar. 17, 2000, which is hereby incorporated by reference herein in its entirety. [0050] Referring to FIGS. [0050] 3-5 the cannula 37 is shown with a two element RF electrode 41 disposed on the distal end 42 of the cannula 37. A outer hollow shaft 55 having an inner lumen 56 is slidingly disposed about an inner shaft 57 having the RF electrode 41 disposed on the distal end 61 of the inner shaft 57. The RF electrode 41 has a first electrode element 62 and a second electrode element 63 which overlap at the intersection with the longitudinal axis 64 of the cannula 37 extending from the distal end 42. This arrangement allows for the first and second electrode elements 62 and 63 to be expandable to an outer transverse dimension equal to or slightly greater than the circumference of the outer hollow shaft 55. This enables easy insertion of the cannula assembly 37 into the patient 10 as the RF electrode 41 is activated and ablates tissue. The expandability and retractability of the RF electrode 41 allows the inner shaft 57 to be withdrawn from the outer hollow shaft 55 prior to insertion to provide access through the outer hollow shaft 55 to a sentinel lymph node 17 or other tissue area of interest within a patient 10. [0051] The RF electrode [0051] 41 is an arcuate shaped wire 65 spaced distally from a distal extremity 66 of the distal end 42 of the cannula 37. When the electrode 41 is activated with RF energy, tissue is ablated along the length of the RF electrode 41 and displaced by the distal end 42 of the cannula 37 as it is advanced through the tissue. FIG. 4 shows the RF electrode 41 on the distal end 42 of the cannula 37 in an expanded state in which the transverse dimension of the RF electrode 41 as a whole is greater than the outer diameter of the outer hollow shaft 55. In FIG. 5, the distal end 61 of the inner shaft 57 of the cannula 37 is withdrawn into the inner lumen 56 of the hollow outer shaft 55 and the RF electrode 41 is in a contracted state within the inner lumen hollow outer shaft. [0052] FIG. 6 shows an outer hollow shaft [0052] 55 of a cannula 37 disposed within a patient 10 with the inner shaft 57 of the cannula 37 withdrawn and the distal end 67 of the outer hollow shaft 55 adjacent a sentinel lymph node 17. A radiation energy detector 71 having a signal processor unit 72, a handle assembly 73 and a radiation detector probe 74 with a proximal end 75 and distal end 76 is positioned to have the distal end 76 of the radiation energy detector probe 74 inserted into the inner lumen 56 of the outer hollow shaft 55. A cable 77 is in communication with the signal processor unit 72 and a proximal end 81 of the handle assembly 73. [0053] In FIG. 7, the radiation energy detector probe [0053] 74 is shown disposed within the outer hollow shaft 55 of the cannula 37. The distal end 76 of the radiation energy detector probe 74 is disposed adjacent a first sentinel lymph node 82 and a second sentinel lymph node 83 with a longitudinal axis 84 of the outer hollow shaft 55 and longitudinal axis 85 of the radiation energy detector probe 74 substantially aligned with the center 86 of the first sentinel lymph node 82. The radiation energy detector probe 74 detects radiation energy emanating from the tissue along the longitudinal axis 85 of the probe 74 in a proximal direction relative to the probe. The hollow outer shaft 55 or the radiation energy detector probe 74 within the outer hollow shaft 55 can be manipulated, as shown in FIG. 8, while in the patient 10 to detect the amount of radiation energy emanating from various portions of the tissue as they pass in front of the distal end 76 of the radiation energy detector probe 74 during the manipulation. [0054] The amount of radiation detected from the various portions of tissue adjacent the longitudinal axis [0054] 84 of the hollow outer shaft 55 can be compared by observation of a visual or audio signal or the like generated by the signal processor unit 72 in order for the operator of the system to determine the position of the radiation energy detector probe 74 where the maximum signal strength exists. The input of the radiation energy detector probe 74 at the distal end 76 of the probe 74 can be configured or collimated so as to maximize output signal strength when a sentinel lymph node 17 emitting a relatively large amount of radiation (“hot” sentinel lymph node) is disposed directly distal of the distal end 76 of the radiation energy detector probe 74. Thus, by maximizing the output signal from the signal processor unit 72, the operator can determine the precise location of a hot sentinel lymph node 17 and effectively discriminate surrounding non-radioactive tissue and non-radioactive nodes. [0055] In FIG. 8, the longitudinal axis [0055] 85 of the detector probe 74 is substantially aligned with the center 86 of the first sentinel lymph node 82. A phantom outline of the distal end of the radiation energy detector probe is also shown substantially aligned with the center 91 of the second sentinel lymph node 92 after manipulation of the distal end 76 of the radiation energy detector probe 74 from the proximal end 75 of the radiation energy detector probe 74 or the proximal end 93 of the outer hollow shaft 55 of the cannula 37. The diameter of the elongate probe 74 of the radiation energy detector distal end can be about 1 to about 6 mm, specifically about 3 to about 5 mm, and more specifically about 4.0 to about 4.4 mm. [0056] A detector body (not shown) is disposed within the distal end [0056] 76 of the elongate radiation energy detector probe 74 which is collimated to receive radiation energy at an angle of up to about 30°, preferably about 10° to about 20°, from a longitudinal axis 85 of the elongate radiation energy detector probe. The detector body can be designed to encompass the radiation emitted from a 1 cm node at a distance of 1 cm. The detector body can be configured or collimated to have enhanced reception of radiation energy from the distal end as opposed to side impingement of radiation energy. The detector body is coupled by the cable 77 to the signal processor unit 72. The detector body can be configured to specifically detect gamma radiation or any other suitable form of radiation energy including alpha or beta radiation. The handle assembly 73 of the radiation energy detector 71 can have a preamplifier within it to increase the signal from the detector body to the signal processor unit 72. The handle 73 typically has a diameter or transverse dimension of about 25-30 mm. The length of the radiation energy detector probe 74 is typically configured to access to a patient's tissue through an inner lumen of a cannula and can be about 5 to about 15 cm. [0057] The signal processor unit [0057] 72 of the radiation energy detector 71 can be configured to emit an audible signal to a user of the detector which has an amplitude which increases logarithmically in relation to an increase in the amount of radiation energy being detected. Alternatively, the detector body signal processor unit 72 can produce a visual signal to a user of the detector which is proportional in amplitude to the amount of radiation energy being detected. The signal processor 72 has a display 95 with a digital readout of counts per second and total counts for given time period. The radiation energy detector 71 can typically detect radiation at useable levels from a hot lymph node from a distance of about 10 to about 12 cm, but is most accurate at a distance of about 2 to about 3 cm. [0058] Referring to FIGS. [0058] 9-19, an anchor device 100 and use thereof is shown. The anchor device 100 has a housing 101, an inner conductor 102, a main shaft 103 disposed within an inner lumen 104 of the inner conductor 102, an actuator 105 coupled to the inner conductor 102 for extending the extension wires 106 and an RF energy generator 107 switchably coupled to the inner conductor 102 and elongate shaft 106 with a proximal end 112 and distal end 113. At least one extension wire 106 is disposed within the distal end 113 of the elongate shaft 111 coupled to a distal end 114 of the inner conductor 102 and having a withdrawn configuration and a deployed configuration extending radially from the distal end 113 of the shaft 111, or in some other suitable direction. A deployment actuator 105 is disposed proximal of the distal end 113 of the elongate shaft 111 and configured to deploy the extension wire 106 from a retracted configuration to an extended configuration. [0059] Markings [0059] 115 on the housing 101, as shown in FIG. 15, may be spaced at predetermined intervals to delineate the diameter of extension of the at least one extension wire 106 by movement of actuator 105. As shown in FIG. 16, a first electrical conductor 116 can be electrically coupled to the inner conductor 102 and the RF energy generator 107 and a second electrical conductor 117 electrically coupled to the patient 121 as a ground plate 122 for the RF energy generator 107. RF energy may be applied to the extension wires during deployment and extension thereof to aid in the advancement thereof through tissue. However, if RF energy is to be applied, the extension wires should be insulated along their lengths except for the distal tips thereof. The first electrical conductor 116 can be coupled to the extension wires 106 at the proximal end of the shaft 111 with a detachable coupler 123. [0060] The anchor device [0060] 100 is generally inserted through the outer hollow shaft 124 of a cannula 125 and into a sentinel lymph node 126. The distal end 127 of the anchor device 100 is then secured to the sentinel lymph node 126. Once the distal end 127 of the anchor device 100 is secured to the lymph node 126, the patient 121 can be transferred to a surgical suite and the lymph node 126 surgically removed with the anchor device 100 attached thereto serving as a locating device. [0061] In the embodiment of the anchor device shown in FIGS. [0061] 9-19, the distal end 127 of the anchor device 100 can be secured to the sentinel lymph node 126 by deploying at least one extension wire 106 from the distal end 127 of the anchor device 100 into the sentinel lymph node 126 as shown in FIG. 18. In addition, an outer extremity 131 of the extension wires 106 can be configured to emit RF energy during deployment of the extension wires so as to ablate tissue adjacent the outer extremities 131 of the extension wires 106 to facilitate advancement through tissue during deployment. Radial extension of the extension wires 106 from the anchor device 100 can be from about 1 to about 30 mm, specifically about 3 to about 25 mm, and more specifically about 5 to about 12 mm when deployed fully. [0062] FIG. 10 shows the anchor device [0062] 100 where the extension wires 106 at the distal end 127 of the anchor device 100 are in a retracted position. A spring loaded electrical contact 132 is disposed within the coupler 123 disposed on the distal end 133 of first conductor 116. The electrical contact 132 is slidingly and electrically coupled to a conductive sleeve 133 which is secured to and in electrical communication with a proximal end 134 of the inner conductor 102. The conductive sleeve 133 is able to slide within the spring loaded contact 132 maintaining an electrical path between conductor 116 and inner conductor 102 while allowing axial translation of the inner conductor 102 relative to the coupler 123 and housing 101. [0063] Actuator switch [0063] 105 is mechanically coupled to inner conductor 102 and slidingly engaged in a slot 135 in the housing 101 with an abutment 136 extending radially from the slot 135 in the housing 101 to facilitate axial movement by the operator of the anchor device 100. In FIG. 10 the actuator switch 105 and abutment 136 are in the most proximal position within the slot 135 which corresponds to the radially retracted position of the extension wires 106. FIG. 11 shows the extension wires 106 in a radially expanded position extending radially outward from a longitudinal axis 137 of the anchor device 100 with the actuator switch 105 in its corresponding most distal forward position. [0064] FIG. 1[0064] 5 shows a top view of the actuator switch 105 of the anchor device 100 in a fully forward distal position corresponding to full extension of the extension wires 106 in an outward radial direction as shown in FIG. 10. Also in FIG. 15 the axial markings 115 can be more clearly seen with numerical designations which may correspond to the diameter or radius of the extension wires 106 at the distal end 127 of the anchor device 100. In FIG. 16 the anchor device 100 is being inserted into an outer hollow shaft 124 of a cannula 125 the distal end 141 of which is disposed adjacent a sentinel lymph node 126. The inner conductor 102 of the anchor device 100 is electrically coupled to a conductor 116 which is in turn electrically coupled to the RF generator 107. A ground pad 122 is in electrical contact with the patient 121 and electrically coupled to the RF generator 107 with a second conductor 117. [0065] FIG. 17 shows the elongate shaft [0065] 111 of the anchor device 100 disposed within an inner lumen 142 of the hollow outer shaft 124 of the cannula 125. The distal end 127 of the anchor device 100 disposed within a sentinel lymph node 126 in the tissue of the patient 121 with the extension wires 106 in a retracted position. In FIG. 18, the extension wires 106 of the anchor device 100 have been extended into the sentinel lymph node 126 and mechanically secured thereto. In FIG. 19, the outer hollow shaft 124 of the cannula 125 and housing 101 of the anchor device 100 are being removed proximally from the patient 121. The elongate shaft 111 of the anchor device 100 remains within the patient 121 with the distal end 127 of the anchor device 100 secured to the sentinel lymph node 126 with the extension wires 106 in an extended position. Thereafter, the patient 121 may be taken to surgery to have the lesion excised or otherwise treated with the elongate shaft 111 of the anchor device 100 serving as a positive location means during the procedure. [0066] In use during a typical procedure, radioactive material [0066] 15 is injected into a patient's body 10 near a primary lesion site 15 or other site of interest within the patient 10. The approximate position of a sentinel lymph node 17 within the patient's body 10 is determined by detecting radiation from the radioactive material 15 accumulated within the sentinel lymph node 17 with a radiation detector 21 or 22 external to the patient's body 10. The sentinel lymph node 17 can then be accessed with a cannula 37 having an RF electrode 41 disposed on a distal end 42 of the cannula 41 by activating the RF electrode to ablate tissue while passing the cannula into the patient's body 10 until the distal end 42 of the cannula 41 is disposed adjacent the sentinel lymph node 17. [0067] Once the distal end [0067] 42 of the cannula 41 is positioned adjacent the sentinel lymph node 17, the proximity of the distal end 42 of the cannula 41 to the sentinel lymph node 17 can be optimized by inserting a radiation energy detector probe 74 into an inner lumen of a hollow outer shaft 55 of the cannula 41 and manipulating a distal end 26 of the radiation energy detector probe 74 so as to positively identify the position of the targeted sentinel node 17 by maximizing radiation energy received by the radiation energy probe from the targeted sentinel node. [0068] An anchor device [0068] 100 can then be inserted through the cannula 41 and into the sentinel lymph node 17. The distal end 127 of the anchor device 100 can then be secured to the sentinel lymph node 17. Once the distal end 127 of the anchor device 100 is secured to the lymph node 17, the patient 10 can be transferred to a surgical suite and the lymph node 17 surgically removed with the anchor device 100 or a portion thereof attached thereto. [0069] Referring to FIG. 20, an alternative embodiment of an anchor device [0069] 150 is shown having features of the invention. The anchor device 150 has extension wires 151 which are radially extendable from the distal end 152 of the anchor device 150, an expandable RF electrode 153 on the distal end 152 of an elongate shaft 154 of the anchor device 150 and a radiation detector probe 155 which is disposed within an inner lumen 156 of the anchor device 150 and which is optionally axially moveable within the inner lumen 156 of the anchor device 150. [0070] The RF electrode [0070] 153 is configured to ablate and penetrate tissue in a manner similar to the RF electrode 41 on the distal end 42 of the cannula 41 discussed above. The RF electrode 153 on the distal end 152 of the elongate shaft 154 is an arcuate wire having two separate electrode elements, a first electrode element 157 and a second electrode element 158, spaced distally from a distal extremity 161 of the distal end 152 of the elongate shaft 154. The RF electrode 153 of the embodiment shown lies in substantially the same plane as a longitudinal axis 162 of the elongate shaft 154 of the anchor device 150. [0071] In use during a typical procedure for this embodiment, radioactive material is injected into a patient's body near a primary lesion site or other site of interest within the patient. The approximate position of a sentinel lymph node within the patient's body is determined by detecting radiation from the radioactive material accumulated within the sentinel lymph node with a radiation detector external to the patient's body. The sentinel lymph node (shown in phantom in FIG. 20) can then be accessed with the anchor device [0071] 150 having the RF electrode 153 disposed on a distal end 152 of the anchor device 150 by activating the RF electrode 153 to ablate tissue while passing the distal end 152 of the anchor device into the patient's body until the distal end 152 of the anchor device is disposed adjacent the sentinel lymph node. [0072] Once the distal end [0072] 152 of the anchor device 150 is positioned adjacent the sentinel lymph node, the proximity of the distal end 152 of the anchor device to the sentinel lymph node can be optimized by manipulating the distal end of the anchor device so as to maximize signal output by the radiation energy detector 155 within the anchor device 150. The distal end 152 of the anchor device 150 can be secured to the sentinel lymph node by the extension of extension wires 151 into the node. Once the distal end 152 of the anchor device 150 is secured to the lymph node, the patient can be transferred to a surgical suite and the lymph node surgically removed with the anchor device attached thereto. [0073] While particular forms of the invention have been illustrated and described, it should be apparent that various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims. [0073]
权利要求:
Claims (33) [1" id="US-20010002250-A1-CLM-00001] 1. A method of locating and accessing a sentinel lymph node of a patient which corresponds to a lesion site within the patient's body comprising: a) injecting a radioactive material near the lesion site of the patient; b) locating the approximate position of at least one sentinel lymph node within the patient's body by detecting radiation from the radioactive material accumulated within the sentinel lymph node with a radiation detector external to the patient's body; and c) accessing the at least one sentinel lymph node with a cannula having an tissue penetrating member disposed on a distal end of the cannula by activating the RF electrode to ablate tissue while passing the cannula into the patient's body until the distal end of the cannula is disposed adjacent the at least one sentinel lymph node. [2" id="US-20010002250-A1-CLM-00002] 2. The method of claim 1 further comprising: a) passing an anchor device through the cannula and into the sentinel lymph node; b) securing the distal end of the anchor device to the at least one sentinel lymph node. [3" id="US-20010002250-A1-CLM-00003] 3. The method of claim 2 wherein the distal end of the anchor device is secured to the sentinel lymph node by deploying at least one extension wire from the distal end of the anchor device into the at least one sentinel lymph node. [4" id="US-20010002250-A1-CLM-00004] 4. The method of claim 3 wherein an outer extremity of the at least one extension wire is configured to emit RF energy and further comprising activating the outer extremity of the at least one extension wire to emit RF energy during deployment thereof. [5" id="US-20010002250-A1-CLM-00005] 5. The method of claim 1 wherein the cannula comprises an outer hollow shaft having an inner lumen slidingly disposed about an inner shaft having an RF electrode disposed on the distal end of the inner shaft and further comprising withdrawing the inner shaft from the outer hollow shaft prior to insertion of the anchor device through the inner lumen of the outer hollow shaft to access the at least one sentinel lymph node. [6" id="US-20010002250-A1-CLM-00006] 6. The method of claim 5 wherein the position of the distal end of the cannula adjacent to the at least one sentinel lymph node is confirmed by inserting a radiation energy detector through the inner lumen of the hollow outer shaft of the cannula and detecting an amount of radiation energy emanating from the tissue along the longitudinal axis of the hollow outer shaft and manipulating the hollow outer shaft and or the radiation energy detector to detect the amount of radiation energy emanating from the tissue adjacent the longitudinal axis of the hollow outer shaft and comparing the amounts of radiation detected from various portions of tissue. [7" id="US-20010002250-A1-CLM-00007] 7. The method of claim 1 wherein a gamma camera is used to determine the approximate position of the at least one sentinel lymph node within the patient's body prior to accessing the sentinel lymph node with the cannula assembly. [8" id="US-20010002250-A1-CLM-00008] 8. The method of claim 1 wherein a hand held radiation detecting wand is used to determine the approximate position of the at least one sentinel lymph node within the patient's body prior to accessing the sentinel lymph node with the cannula. [9" id="US-20010002250-A1-CLM-00009] 9. The method of claim 1 wherein the cannula and sentinel lymph node are imaged with an ultrasound imaging system during insertion of the cannula into the patient's body. [10" id="US-20010002250-A1-CLM-00010] 10. The method of claim 2 further comprising surgically removing the at least one sentinel lymph node with the anchor device attached thereto and using the anchor device to locate the at least one sentinel lymph node during the surgical procedure. [11" id="US-20010002250-A1-CLM-00011] 11. The method of claim 1 further comprising marking the skin of the patient with a visible mark above the location of the sentinel lymph node prior to accessing the sentinel lymph node with the cannula. [12" id="US-20010002250-A1-CLM-00012] 12. The method of claim 1 wherein the tissue penetrating member is an RF powered electrode. [13" id="US-20010002250-A1-CLM-00013] 13. The method of claim 12 wherein the RF electrode comprises an arcuate shaped wire spaced distally from a distal extremity of the distal end of the cannula whereby tissue is ablated along the length of the RF electrode and displaced by the distal end of the cannula as it is advanced through the tissue. [14" id="US-20010002250-A1-CLM-00014] 14. A system for locating and accessing a desired portion of radioactive tissue within a patient, comprising: a) an accessing device having i. an elongated cannula having proximal and distal ends and ports in the proximal and distal ends, and ii. an accessing probe having a distal end and a tissue penetrating member on the distal end and being configured to be slidably disposed within the inner lumen of the cannula; b) an elongated radiation detecting probe configured to be slidably disposed within the inner lumen of the cannula of the accessing device; and c) an anchoring device having i. an elongate shaft having a proximal end and a distal end, ii. at least one extension wire having a withdrawn configuration and a deployed configuration extending from the distal end of the shaft, and iii. a deployment actuator disposed proximal of the distal end of the elongate shaft and configured to deploy the extension wire from a retracted configuration to an extended configuration. [15" id="US-20010002250-A1-CLM-00015] 15. The system of claim 14 wherein the anchoring device further comprises markings spaced at predetermined intervals to delineate the diameter of extension of the at least one extension wire. [16" id="US-20010002250-A1-CLM-00016] 16. The system of claim 14 wherein the anchor device further comprises a first electrical lead electrically coupled to the at least one extension wire and a second electrical lead electrically coupled to the patient whereby RF energy can be applied to the at least one extension wire during deployment and extension thereof. [17" id="US-20010002250-A1-CLM-00017] 17. The system of claim 16 wherein the first electrical lead of the anchor probe is coupled to the extension wire at the proximal end of the shaft with a detachable connector. [18" id="US-20010002250-A1-CLM-00018] 18. The system of claim 14 wherein the anchor device further comprises an RF electrode on the distal end of the elongate shaft configured to ablate and penetrate tissue. [19" id="US-20010002250-A1-CLM-00019] 19. The system of claim 18 wherein the RF electrode on the distal end of the elongate shaft of the anchor device comprises an arcuate wire spaced distally from the distal extremity of the distal end of the elongate shaft. [20" id="US-20010002250-A1-CLM-00020] 20. The system of claim 19 wherein the RF electrode lies in substantially the same plane as the longitudinal axis of the elongate shaft of the anchor device. [21" id="US-20010002250-A1-CLM-00021] 21. The system of claim 14 wherein the deployment actuator of the anchoring device is configured to both extend the extension wires and activate RF energy to the extension wires. [22" id="US-20010002250-A1-CLM-00022] 22. The system of claim 14 wherein the anchor device further comprises a housing, an inner conductor, a main shaft disposed within an inner lumen of the inner conductor, an actuator coupled to the inner conductor for extending the extension wires and an RF energy source switchably coupled to the inner conductor. [23" id="US-20010002250-A1-CLM-00023] 23. A radiation energy detector for locating the position of radioactive tissue within the body of a patient comprising: a) an elongate shaft having a proximal end, a distal end and an outer transverse dimension of the distal end of up to about 4 mm; b) a detector body disposed at the distal end of the elongate shaft which is collimated to receive radiation energy at an angle of up to about 30° from a longitudinal axis of the elongate shaft; c) a detector body signal processor coupled to the detector body. [24" id="US-20010002250-A1-CLM-00024] 24. The radiation energy detector of claim 23 further comprising a handle disposed at the proximal end of the elongate shaft. [25" id="US-20010002250-A1-CLM-00025] 25. The radiation energy detector of claim 23 wherein the detector body is collimated to accept radiation energy at an angle of about 10° to about 20° with respect to the longitudinal axis of the elongate shaft. [26" id="US-20010002250-A1-CLM-00026] 26. The radiation energy detector of claim 23 wherein the detector body is configured to detect gamma radiation. [27" id="US-20010002250-A1-CLM-00027] 27. The radiation energy detector of claim 23 wherein the distal end of the elongate shaft has an outer transverse dimension of about 2 to about 2-6 mm. [28" id="US-20010002250-A1-CLM-00028] 28. The radiation energy detector of claim 23 wherein the distal end of the elongate shaft has an outer transverse dimension of about 2 to about 3-8 mm. [29" id="US-20010002250-A1-CLM-00029] 29. The radiation energy detector of claim 23 wherein the length of the elongate shaft is configured to access to a patient's tissue through an inner lumen of a cannula and is about 5 to about 15 cm. [30" id="US-20010002250-A1-CLM-00030] 30. The radiation detector of claim 23 wherein the elongate shaft comprises a hollow metallic tube and has a length of about 8 to about 12 cm. [31" id="US-20010002250-A1-CLM-00031] 31. The radiation detector of claim 23 wherein the elongate shaft is comprised of stainless steel. [32" id="US-20010002250-A1-CLM-00032] 32. The radiation detector of claim 23 wherein the detector body signal processor emits an audible signal to a user of the detector which has an amplitude which increases logarithmically in relation to an increase in the amount of radiation energy being detected. [33" id="US-20010002250-A1-CLM-00033] 33. The radiation detector of claim 22 wherein the detector body signal processor produces a visual signal to a user of the detector which is proportional in amplitude to the amount of radiation energy being detected.
类似技术:
公开号 | 公开日 | 专利标题 US6716179B2|2004-04-06|Sentinel node location and biopsy US7282034B2|2007-10-16|Tissue accessing and anchoring device and method EP1091685B1|2008-06-11|Devices for the localization of lesions in solid tissue US6540695B1|2003-04-01|Biopsy anchor device with cutter EP1109496B1|2012-05-09|Securing surgical instruments at target tissue sites US6484050B1|2002-11-19|Minimally invasive surgical instrument for tissue identification, dislodgment and retrieval and methods of use US6312429B1|2001-11-06|Electrosurgical lesion location device WO2001049184A9|2002-10-31|Radiofrequency apparatus and method for accessing a biopsy site WO1999025248A1|1999-05-27|Minimally invasive surgical probe for tissue identification and retrieval and method of use US20150157405A1|2015-06-11|Needle catheter utilizing optical spectroscopy for tumor identification and ablation CA2557170A1|2005-10-13|System and method for tissue sampling and therapeutic treatment Doniec et al.2000|3487 Rectal eus guided hdr-brachytherapy in patients with anal and perianal malignancies. Palazzo et al.2000|3485 Cystogastrostomy with 10 french stent entirely performed under endosonography guidance for pancreatic pseudocyst. Barawi et al.2000|3488 A prospective evaluation of endoscopic ultrasound-guided fine needle aspiration biopsy utilizing a new disposable 22 gauge fna needle device: results of diagnostic accuracy and complications from a large single center series. Swain et al.2000|3486 A new device for endoscopic submucosal resection. US20120083653A1|2012-04-05|Guided procedural treatment device and method
同族专利:
公开号 | 公开日 JP2004533273A|2004-11-04| US20020115943A1|2002-08-22| AU3649002A|2002-06-11| US6638234B2|2003-10-28| WO2002043563A3|2003-02-06| US6716179B2|2004-04-06| WO2002043563A2|2002-06-06|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题 WO2002043563A2|2000-11-29|2002-06-06|Senorx, Inc.|Sentinel node location and biopsy| WO2002100286A1|2001-06-12|2002-12-19|Senorx, Inc.|Tissue accessing and anchoring device and method| WO2004000126A1|2002-06-21|2003-12-31|Senorx, Inc.|Apparatus and method for accessing a body site| US20050065453A1|2003-02-24|2005-03-24|Senorx, Inc.|Biopsy device with selectable tissue receiving aperture orientation and site illumination| US20050159677A1|2003-12-23|2005-07-21|Shabaz Martin V.|Biopsy device with aperture orientation and improved tip| US20050240193A1|2003-09-03|2005-10-27|Kyphon Inc.|Devices for creating voids in interior body regions and related methods| US20070015987A1|2002-10-01|2007-01-18|Benlloch Baviera Jose M|Functional navigator| US20070038146A1|2005-08-05|2007-02-15|Quick Richard L|Biopsy device with fluid delivery to tissue specimens| US7334594B2|2005-06-29|2008-02-26|Codman & Shurtleff, Inc.|Apparatus and method for adjusting a locking mechanism of a shunt valve| US20080058675A1|2004-12-16|2008-03-06|Senorx, Inc.|Biopsy device with aperture orientation and improved tip| US20080281323A1|1999-01-27|2008-11-13|Burbank Fred H|Tissue specimen isolating and damaging device and method| US20080319468A1|2003-02-24|2008-12-25|Senorx, Inc.|Biopsy device with selectable tissue receiving aperature orientation and site illumination| US20090112118A1|2005-08-05|2009-04-30|Senorx, Inc.|Biopsy device with fluid delivery to tissue specimens| US7572256B2|1999-06-22|2009-08-11|Senorx, Inc.|Shaped scalpel| US20090204021A1|2004-12-16|2009-08-13|Senorx, Inc.|Apparatus and method for accessing a body site| US20090270912A1|2008-04-23|2009-10-29|Wilson-Cook Medical Inc.|Tacking device| US20100049208A1|2008-08-19|2010-02-25|Wilson-Cook Medical Inc.|Apparatus and methods for removing lymph nodes or anchoring into tissue during a translumenal procedure| US20100069955A1|2008-09-11|2010-03-18|Wilson-Cook Medical Inc.|Methods for facilitating closure of a bodily opening using one or more tacking devices| US20100145362A1|2008-12-09|2010-06-10|Wilson-Cook Medical Inc.|Apparatus and methods for controlled release of tacking devices| US20100160931A1|2008-12-19|2010-06-24|Wilson-Cook Medical Inc.|Variable thickness tacking devices and methods of delivery and deployment| US20100160935A1|2008-12-19|2010-06-24|Wilson-Cook Medical Inc.|Clip devices and methods of delivery and deployment| US20100305591A1|2009-05-28|2010-12-02|Wilson-Cook Medical Inc.|Tacking device and methods of deployment| US8123714B2|2007-06-29|2012-02-28|Codman & Shurtleff, Inc.|Programmable shunt with electromechanical valve actuator| US8500760B2|2008-12-09|2013-08-06|Cook Medical Technologies Llc|Retractable tacking device| US8641640B2|2005-05-23|2014-02-04|Senorx, Inc.|Tissue cutting member for a biopsy device| US20140236145A1|2013-02-19|2014-08-21|Boston Scientific Scimed, Inc.|Devices and methods for minimally invasive reduction of parathyroid adenomas| US20150011853A1|2011-05-05|2015-01-08|Nemodevices Ag|Measuring Device for Measuring Cerebral Parameters| WO2018015782A1|2016-07-16|2018-01-25|Injeq Oy|A biopsy gun, a biopsy needle, a biopsy sample collecting system and a method for connecting at least one needle electrode of a biopsy needle to a connector and/or to a measurement cable in a biopsy gun| US10022089B2|2012-11-06|2018-07-17|Luciole Medical AG|Measuring device for determining cerebral parameters| CN108618831A|2018-05-28|2018-10-09|刘方舟|A kind of novel drag hook of dissection| CN109310822A|2016-05-16|2019-02-05|艾斯曲尔医疗公司|Injection device| US10682100B2|2013-05-22|2020-06-16|Luciole Medical AG|Measurement system and method for measuring parameters in a body tissue|US2032860A|1933-03-24|1936-03-03|Wappler Frederick Charles|Method for electrosurgical treatment of tissue| US2192270A|1938-05-25|1940-03-05|American Brake Co|Brake rigging| US3341417A|1965-07-14|1967-09-12|Edwin S Sinaiko|Method of and means for diagnosis of ingested drugs with radio-opaque and other indicators| US3823212A|1968-11-27|1974-07-09|Freudenberg C Fa|Process for the production of collagen fiber fabrics in the form of felt-like membranes or sponge-like layers| CS151338B1|1971-01-22|1973-10-19||| DE2132808C3|1971-07-01|1981-10-29|Deyhle, Peter, Dr.med., 8520 Erlangen|Device for the diathermic removal of growths| US4197846A|1974-10-09|1980-04-15|Louis Bucalo|Method for structure for situating in a living body agents for treating the body| US3955578A|1974-12-23|1976-05-11|Cook Inc.|Rotatable surgical snare| US4007732A|1975-09-02|1977-02-15|Robert Carl Kvavle|Method for location and removal of soft tissue in human biopsy operations| US4243048A|1976-09-21|1981-01-06|Jim Zegeer|Biopsy device| US4294241A|1977-06-09|1981-10-13|Teruo Miyata|Collagen skin dressing| GB2011258A|1977-11-18|1979-07-11|Wolf Gmbh Richard|Device for removing excrescences and polyps| US4294254A|1977-12-08|1981-10-13|Chamness Dale L|Surgical apparatus| US4172449A|1978-05-01|1979-10-30|New Research And Development Laboratories, Inc.|Body fluid pressure monitor| JPS619051B2|1978-10-12|1986-03-19|Olympus Optical Co|| US4276885A|1979-05-04|1981-07-07|Rasor Associates, Inc|Ultrasonic image enhancement| GB2053691B|1979-07-24|1983-04-27|Wolf Gmbh Richard|Endoscopes| US4331654A|1980-06-13|1982-05-25|Eli Lilly And Company|Magnetically-localizable, biodegradable lipid microspheres| US4565200A|1980-09-24|1986-01-21|Cosman Eric R|Universal lesion and recording electrode system| US4425908A|1981-10-22|1984-01-17|Beth Israel Hospital|Blood clot filter| DE3247793C2|1981-12-31|1986-01-09|Harald 7200 Tuttlingen Maslanka|High frequency surgical loop electrode| US4545367A|1982-07-16|1985-10-08|Cordis Corporation|Detachable balloon catheter and method of use| US4576162A|1983-03-30|1986-03-18|Mccorkle Charles E|Apparatus and method for separation of scar tissue in venous pathway| DE3419962A1|1983-05-30|1984-12-06|Olympus Optical Co., Ltd., Tokio/Tokyo|HIGH FREQUENCY INCISION AND EXCISION INSTRUMENT| US4647480A|1983-07-25|1987-03-03|Amchem Products, Inc.|Use of additive in aqueous cure of autodeposited coatings| USRE33925E|1984-05-22|1992-05-12|Cordis Corporation|Electrosurgical catheter aned method for vascular applications| JPS6176147A|1984-09-21|1986-04-18|Olympus Optical Co|High frequency incision appliance| US4592356A|1984-09-28|1986-06-03|Pedro Gutierrez|Localizing device| US4724836A|1985-01-08|1988-02-16|Olympus Optical Co., Ltd.|High-frequency incision tool| US4616656A|1985-03-19|1986-10-14|Nicholson James E|Self-actuating breast lesion probe and method of using| US4863470A|1985-03-19|1989-09-05|Medical Engineering Corporation|Identification marker for a breast prosthesis| US4718419A|1985-08-05|1988-01-12|Olympus Optical Co., Ltd.|Snare assembly for endoscope| US4847049A|1985-12-18|1989-07-11|Vitaphore Corporation|Method of forming chelated collagen having bactericidal properties| US4693237A|1986-01-21|1987-09-15|Hoffman Richard B|Radiopaque coded ring markers for use in identifying surgical grafts| US4682606A|1986-02-03|1987-07-28|Decaprio Vincent H|Localizing biopsy apparatus| US5066295A|1986-05-13|1991-11-19|Mill-Rose Laboratories, Inc.|Rotatable surgical snare| EP0402955B1|1986-07-30|1994-03-09|Sumitomo Pharmaceuticals Company, Limited|Solid preparation administering instrument| US4813062A|1986-08-13|1989-03-14|Milliken Research Corporation|Radio-opaque marker and method| US4774948A|1986-11-24|1988-10-04|Markham Charles W|Marking and retraction needle having retrievable stylet| US5151598A|1987-03-17|1992-09-29|Neoprobe Corporation|Detector and localizer for low energy radiation emissions| AT134887T|1987-05-26|1996-03-15|Sumitomo Pharma|DEVICE FOR ADMINISTERING SOLID PREPARATIONS| US5372138A|1988-03-21|1994-12-13|Boston Scientific Corporation|Acousting imaging catheters and the like| GB8822492D0|1988-09-24|1988-10-26|Considine J|Apparatus for removing tumours from hollow organs of body| US4909250A|1988-11-14|1990-03-20|Smith Joseph R|Implant system for animal identification| US4966583A|1989-02-03|1990-10-30|Elie Debbas|Apparatus for locating a breast mass| US5024617A|1989-03-03|1991-06-18|Wilson-Cook Medical, Inc.|Sphincterotomy method and device having controlled bending and orientation| GB2230191B|1989-04-15|1992-04-22|Robert Graham Urie|Lesion location device| DE3916161C2|1989-05-18|1991-06-13|Richard Wolf Gmbh, 7134 Knittlingen, De|| US4959547A|1989-06-08|1990-09-25|Care Wise Medical Products Corporation|Apparatus and methods for detecting, localizing, and imaging of radiation in biological systems| US5234426A|1989-06-15|1993-08-10|Research Corporation Technologies, Inc.|Helical-tipped lesion localization needle device and method of using the same| USRE34056E|1989-07-31|1992-09-08|C.R. Bard, Inc.|Tissue sampling device| US5007908A|1989-09-29|1991-04-16|Everest Medical Corporation|Electrosurgical instrument having needle cutting electrode and spot-coag electrode| US5335671A|1989-11-06|1994-08-09|Mectra Labs, Inc.|Tissue removal assembly with provision for an electro-cautery device| US5797907A|1989-11-06|1998-08-25|Mectra Labs, Inc.|Electrocautery cutter| US5158084A|1989-11-22|1992-10-27|Board Of Regents, The University Of Texas System|Modified localization wire for excisional biopsy| US5197846A|1989-12-22|1993-03-30|Hitachi, Ltd.|Six-degree-of-freedom articulated robot mechanism and assembling and working apparatus using same| US5334381A|1989-12-22|1994-08-02|Unger Evan C|Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same| US5035696A|1990-02-02|1991-07-30|Everest Medical Corporation|Electrosurgical instrument for conducting endoscopic retrograde sphincterotomy| US5047027A|1990-04-20|1991-09-10|Everest Medical Corporation|Tumor resector| US5080660A|1990-05-11|1992-01-14|Applied Urology, Inc.|Electrosurgical electrode| US5078716A|1990-05-11|1992-01-07|Doll Larry F|Electrosurgical apparatus for resecting abnormal protruding growth| US5163938A|1990-07-19|1992-11-17|Olympus Optical Co., Ltd.|High-frequency surgical treating device for use with endoscope| US5201741A|1990-07-24|1993-04-13|Andrew Surgical, Inc.|Surgical snare with shape memory effect wire| US5236410A|1990-08-02|1993-08-17|Ferrotherm International, Inc.|Tumor treatment method| US5100423A|1990-08-21|1992-03-31|Medical Engineering & Development Institute, Inc.|Ablation catheter| US5111828A|1990-09-18|1992-05-12|Peb Biopsy Corporation|Device for percutaneous excisional breast biopsy| US5353804A|1990-09-18|1994-10-11|Peb Biopsy Corporation|Method and device for percutaneous exisional breast biopsy| US5221269A|1990-10-15|1993-06-22|Cook Incorporated|Guide for localizing a nonpalpable breast lesion| US5282781A|1990-10-25|1994-02-01|Omnitron International Inc.|Source wire for localized radiation treatment of tumors| IL96352A|1990-11-14|1994-11-11|Du Kedem Tech Ltd|Hard tissue biopsy instrument| US5984919A|1991-02-13|1999-11-16|Applied Medical Resources Corporation|Surgical trocar| DE69229902T2|1991-02-13|2000-05-04|Applied Med Resources|SURGICAL TROCAR| US5370901A|1991-02-15|1994-12-06|Bracco International B.V.|Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients| DE59203043D1|1991-03-06|1995-08-31|Sueddeutsche Feinmechanik|CANNULES FOR DEPOSITING AN ELEMENT.| US5205290A|1991-04-05|1993-04-27|Unger Evan C|Low density microspheres and their use as contrast agents for computed tomography| US5323768A|1991-04-22|1994-06-28|Olympus Optical Co., Ltd.|Diathermic dissector with a bifurcation having substantially the same cross-sectional area as a lumen for guiding a wire| US5324288A|1991-04-30|1994-06-28|Utah Medical Products, Inc.|Electrosurgical loop with a depth gauge| US5484436A|1991-06-07|1996-01-16|Hemostatic Surgery Corporation|Bi-polar electrosurgical instruments and methods of making| US5196007A|1991-06-07|1993-03-23|Alan Ellman|Electrosurgical handpiece with activator| US5147307A|1991-06-17|1992-09-15|Gluck Seymour M|Anatomical marker device and method| US5902272A|1992-01-07|1999-05-11|Arthrocare Corporation|Planar ablation probe and method for electrosurgical cutting and ablation| US5395312A|1991-10-18|1995-03-07|Desai; Ashvin|Surgical tool| US5665085A|1991-11-01|1997-09-09|Medical Scientific, Inc.|Electrosurgical cutting tool| US5674468A|1992-03-06|1997-10-07|Nycomed Imaging As|Contrast agents comprising gas-containing or gas-generating polymer microparticles or microballoons| US5158561A|1992-03-23|1992-10-27|Everest Medical Corporation|Monopolar polypectomy snare with coagulation electrode| US5217458A|1992-04-09|1993-06-08|Everest Medical Corporation|Bipolar biopsy device utilizing a rotatable, single-hinged moving element| US5201732A|1992-04-09|1993-04-13|Everest Medical Corporation|Bipolar sphincterotomy utilizing side-by-side parallel wires| US5207686A|1992-04-15|1993-05-04|Stuart Dolgin|Surgical snare| US5318564A|1992-05-01|1994-06-07|Hemostatic Surgery Corporation|Bipolar surgical snare and methods of use| US5293863A|1992-05-08|1994-03-15|Loma Linda University Medical Center|Bladed endoscopic retractor| NL9200844A|1992-05-13|1993-12-01|De Wijdeven Gijsbertus G P Van|DEVICE AND METHOD FOR INJECTING WITH A SOLID SUBSTANCE.| US5281218A|1992-06-05|1994-01-25|Cardiac Pathways Corporation|Catheter having needle electrode for radiofrequency ablation| US5470308A|1992-08-12|1995-11-28|Vidamed, Inc.|Medical probe with biopsy stylet| US5370675A|1992-08-12|1994-12-06|Vidamed, Inc.|Medical probe device and method| US5409453A|1992-08-12|1995-04-25|Vidamed, Inc.|Steerable medical probe with stylets| US5741225A|1992-08-12|1998-04-21|Rita Medical Systems|Method for treating the prostate| US5224488A|1992-08-31|1993-07-06|Neuffer Francis H|Biopsy needle with extendable cutting means| US5368030A|1992-09-09|1994-11-29|Izi Corporation|Non-invasive multi-modality radiographic surface markers| US5312400A|1992-10-09|1994-05-17|Symbiosis Corporation|Cautery probes for endoscopic electrosurgical suction-irrigation instrument| US5449382A|1992-11-04|1995-09-12|Dayton; Michael P.|Minimally invasive bioactivated endoprosthesis for vessel repair| US5380321A|1992-11-04|1995-01-10|Yoon; Inbae|Shielded energy transmitting surgical instrument and methods therefor| CA2102084A1|1992-11-09|1994-05-10|Howard C. Topel|Surgical cutting instrument for coring tissue affixed thereto| DK12293D0|1993-02-02|1993-02-02|Novo Nordisk As|HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE| US5417687A|1993-04-30|1995-05-23|Medical Scientific, Inc.|Bipolar electrosurgical trocar| US5409004A|1993-06-11|1995-04-25|Cook Incorporated|Localization device with radiopaque markings| DE69432148T2|1993-07-01|2003-10-16|Boston Scient Ltd|CATHETER FOR IMAGE DISPLAY, DISPLAY OF ELECTRICAL SIGNALS AND ABLATION| US5417697A|1993-07-07|1995-05-23|Wilk; Peter J.|Polyp retrieval assembly with cauterization loop and suction web| US5501654A|1993-07-15|1996-03-26|Ethicon, Inc.|Endoscopic instrument having articulating element| US5494030A|1993-08-12|1996-02-27|Trustees Of Dartmouth College|Apparatus and methodology for determining oxygen in biological systems| US5376094A|1993-08-19|1994-12-27|Boston Scientific Corporation|Improved actuating handle with pulley system for providing mechanical advantage to a surgical working element| US5431649A|1993-08-27|1995-07-11|Medtronic, Inc.|Method and apparatus for R-F ablation| EP0643980B1|1993-09-21|1998-12-30|United States Surgical Corporation|Surgical instrument for expanding body tissue| US5415656A|1993-09-28|1995-05-16|American Medical Systems, Inc.|Electrosurgical apparatus| US5437665A|1993-10-12|1995-08-01|Munro; Malcolm G.|Electrosurgical loop electrode instrument for laparoscopic surgery| US5728143A|1995-08-15|1998-03-17|Rita Medical Systems, Inc.|Multiple antenna ablation apparatus and method| US5683384A|1993-11-08|1997-11-04|Zomed|Multiple antenna ablation apparatus| US5735847A|1995-08-15|1998-04-07|Zomed International, Inc.|Multiple antenna ablation apparatus and method with cooling element| US5433204A|1993-11-16|1995-07-18|Camilla Olson|Method of assessing placentation| US5487385A|1993-12-03|1996-01-30|Avitall; Boaz|Atrial mapping and ablation catheter system| US5445142A|1994-03-15|1995-08-29|Ethicon Endo-Surgery, Inc.|Surgical trocars having optical tips defining one or more viewing ports| US5526822A|1994-03-24|1996-06-18|Biopsys Medical, Inc.|Method and apparatus for automated biopsy and collection of soft tissue| US5649547A|1994-03-24|1997-07-22|Biopsys Medical, Inc.|Methods and devices for automated biopsy and collection of soft tissue| US5422730A|1994-03-25|1995-06-06|Barlow; Clyde H.|Automated optical detection of tissue perfusion by microspheres| US5653718A|1994-05-16|1997-08-05|Yoon; Inbae|Cannula anchoring system| US5542948A|1994-05-24|1996-08-06|Arrow Precision Products, Inc.|Surgical combination inject and snare apparatus| DE4424394B4|1994-07-13|2004-12-16|Bip Acquisition Company Inc., Wilmington|Device for marking tissue sites| US5794626A|1994-08-18|1998-08-18|Kieturakis; Maciej J.|Excisional stereotactic apparatus| US5643282A|1994-08-22|1997-07-01|Kieturakis; Maciej J.|Surgical instrument and method for removing tissue from an endoscopic workspace| CA2199864C|1994-09-16|2006-06-20|Seth A. Foerster|Methods and devices for defining and marking tissue| US5954670A|1994-10-05|1999-09-21|Baker; Gary H.|Mandrel-guided tandem multiple channel biopsy guide device and method of use| US5611803A|1994-12-22|1997-03-18|Urohealth Systems, Inc.|Tissue segmentation device| US5643246A|1995-02-24|1997-07-01|Gel Sciences, Inc.|Electromagnetically triggered, responsive gel based drug delivery device| US5947964A|1995-03-03|1999-09-07|Neothermia Corporation|Methods and apparatus for therapeutic cauterization of predetermined volumes of biological tissue| US5795308A|1995-03-09|1998-08-18|Russin; Lincoln D.|Apparatus for coaxial breast biopsy| CA2168694A1|1995-03-20|1996-09-21|Wayne P. Young|Trocar assembly with electrocautery penetrating tip| US5868740A|1995-03-24|1999-02-09|Board Of Regents-Univ Of Nebraska|Method for volumetric tissue ablation| US5700273A|1995-07-14|1997-12-23|C.R. Bard, Inc.|Wound closure apparatus and method| DE19528440C2|1995-08-02|1998-09-10|Harald Dr Med Kuebler|Surgical cutting instrument| US5782775A|1995-10-20|1998-07-21|United States Surgical Corporation|Apparatus and method for localizing and removing tissue| US5732704A|1995-10-13|1998-03-31|Neoprobe Corporation|Radiation based method locating and differentiating sentinel nodes| US5857463A|1995-10-13|1999-01-12|Neoprobe Corporation|Remotely controlled apparatus and system for tracking and locating a source of photoemissions| US5800445A|1995-10-20|1998-09-01|United States Surgical Corporation|Tissue tagging device| CA2187975C|1995-10-20|2001-05-01|Lisa W. Heaton|Surgical apparatus and method for marking tissue location| US5782764A|1995-11-07|1998-07-21|Iti Medical Technologies, Inc.|Fiber composite invasive medical instruments and methods for use in interventional imaging procedures| US5752972A|1995-11-09|1998-05-19|Hoogeboom; Thomas J.|Modular endoscopic surgical instrument| US5755697A|1995-11-22|1998-05-26|Jones; Calvin E.|Self-tunneling, self-securing percutaneous catheterization device and method of use thereof| US5687739A|1995-12-06|1997-11-18|Interventional Concepts, Inc.|Biopsy specimen cutter| US5769086A|1995-12-06|1998-06-23|Biopsys Medical, Inc.|Control system and method for automated biopsy device| US5636255A|1996-03-05|1997-06-03|Queen's University At Kingston|Method and apparatus for CT image registration| DE19706751A1|1996-03-27|1997-10-02|Valleylab Inc|Electrosurgical device for removing tissue in body areas| US5725521A|1996-03-29|1998-03-10|Eclipse Surgical Technologies, Inc.|Depth stop apparatus and method for laser-assisted transmyocardial revascularization and other surgical applications| DE19626408A1|1996-07-01|1998-01-08|Berchtold Gmbh & Co Geb|Trocar for laparoscopic operations| US5766163A|1996-07-03|1998-06-16|Eclipse Surgical Technologies, Inc.|Controllable trocar for transmyocardial revascularization via endocardium method and apparatus| US5853366A|1996-07-08|1998-12-29|Kelsey, Inc.|Marker element for interstitial treatment and localizing device and method using same| US5902310A|1996-08-12|1999-05-11|Ethicon Endo-Surgery, Inc.|Apparatus and method for marking tissue| US5913857A|1996-08-29|1999-06-22|Ethicon End0-Surgery, Inc.|Methods and devices for collection of soft tissue| US5810806A|1996-08-29|1998-09-22|Ethicon Endo-Surgery|Methods and devices for collection of soft tissue| US5876340A|1997-04-17|1999-03-02|Irvine Biomedical, Inc.|Ablation apparatus with ultrasonic imaging capabilities| US5846513B1|1997-07-08|2000-11-28|Carewise Medical Products Corp|Tumor localization and removal system using penetratable detection probe and removal instrument| US5928150A|1997-10-04|1999-07-27|Neoprobe Corporation|System for locating and detecting a source of photon emissions| US5916167A|1997-10-10|1999-06-29|Neoprobe Corporation|Surgical probe apparatus and system| US6063082A|1997-11-04|2000-05-16|Scimed Life Systems, Inc.|Percutaneous myocardial revascularization basket delivery system and radiofrequency therapeutic device| US6484050B1|1997-11-18|2002-11-19|Care Wise Medical Products Corporation|Minimally invasive surgical instrument for tissue identification, dislodgment and retrieval and methods of use| US5961458A|1997-11-18|1999-10-05|Carewise Medical Products Corporation|Minimally invasive surgical probe for tissue identification and retrieval and method of use| US6471700B1|1998-04-08|2002-10-29|Senorx, Inc.|Apparatus and method for accessing biopsy site| US6540693B2|1998-03-03|2003-04-01|Senorx, Inc.|Methods and apparatus for securing medical instruments to desired locations in a patients body| US6638234B2|1998-03-03|2003-10-28|Senorx, Inc.|Sentinel node location and biopsy| US6312429B1|1998-09-01|2001-11-06|Senorx, Inc.|Electrosurgical lesion location device| US6679851B2|1998-09-01|2004-01-20|Senorx, Inc.|Tissue accessing and anchoring device and method| US5964716A|1998-05-14|1999-10-12|Ethicon Endo-Surgery, Inc.|Method of use for a multi-port biopsy instrument| US6363940B1|1998-05-14|2002-04-02|Calypso Medical Technologies, Inc.|System and method for bracketing and removing tissue| US5972002A|1998-06-02|1999-10-26|Cabot Technology Corporation|Apparatus and method for surgical ligation| US6056700A|1998-10-13|2000-05-02|Emx, Inc.|Biopsy marker assembly and method of use| US6161034A|1999-02-02|2000-12-12|Senorx, Inc.|Methods and chemical preparations for time-limited marking of biopsy sites| US6234177B1|1999-08-12|2001-05-22|Thomas Barsch|Apparatus and method for deploying an expandable biopsy marker|US6626903B2|1997-07-24|2003-09-30|Rex Medical, L.P.|Surgical biopsy device| US7637948B2|1997-10-10|2009-12-29|Senorx, Inc.|Tissue marking implant| US8668737B2|1997-10-10|2014-03-11|Senorx, Inc.|Tissue marking implant| US6540693B2|1998-03-03|2003-04-01|Senorx, Inc.|Methods and apparatus for securing medical instruments to desired locations in a patients body| US6371904B1|1998-12-24|2002-04-16|Vivant Medical, Inc.|Subcutaneous cavity marking device and method| US9669113B1|1998-12-24|2017-06-06|Devicor Medical Products, Inc.|Device and method for safe location and marking of a biopsy cavity| US8498693B2|1999-02-02|2013-07-30|Senorx, Inc.|Intracorporeal marker and marker delivery device| US8361082B2|1999-02-02|2013-01-29|Senorx, Inc.|Marker delivery device with releasable plug| US6862470B2|1999-02-02|2005-03-01|Senorx, Inc.|Cavity-filling biopsy site markers| US9820824B2|1999-02-02|2017-11-21|Senorx, Inc.|Deployment of polysaccharide markers for treating a site within a patent| EP1919388B1|2000-11-20|2012-12-26|Senorx, Inc.|Tissue site markers for in vivo imaging| US6725083B1|1999-02-02|2004-04-20|Senorx, Inc.|Tissue site markers for in VIVO imaging| US6611402B1|1999-06-09|2003-08-26|Seagate Technology Llc|Pitch-adjustable head suspension with end lift tab for dynamic load/unload| US6575991B1|1999-06-17|2003-06-10|Inrad, Inc.|Apparatus for the percutaneous marking of a lesion| US8083768B2|2000-12-14|2011-12-27|Ensure Medical, Inc.|Vascular plug having composite construction| US6623509B2|2000-12-14|2003-09-23|Core Medical, Inc.|Apparatus and methods for sealing vascular punctures| US6896692B2|2000-12-14|2005-05-24|Ensure Medical, Inc.|Plug with collet and apparatus and method for delivering such plugs| US6846319B2|2000-12-14|2005-01-25|Core Medical, Inc.|Devices for sealing openings through tissue and apparatus and methods for delivering them| US6890343B2|2000-12-14|2005-05-10|Ensure Medical, Inc.|Plug with detachable guidewire element and methods for use| GB0120645D0|2001-08-24|2001-10-17|Smiths Group Plc|Medico-surgical devices| US7651505B2|2002-06-17|2010-01-26|Senorx, Inc.|Plugged tip delivery for marker placement| US7931658B2|2002-09-20|2011-04-26|Interrad Medical, Inc.|Temporary retention device| DE60330705D1|2002-11-18|2010-02-04|Bard Peripheral Vascular Inc|DEVICE FOR IMPLANTING A PRE-LOADED LOCALIZATION WIRE| US20060036158A1|2003-11-17|2006-02-16|Inrad, Inc.|Self-contained, self-piercing, side-expelling marking apparatus| GB0307350D0|2003-03-29|2003-05-07|Smiths Group Plc|Catheters| US7983734B2|2003-05-23|2011-07-19|Senorx, Inc.|Fibrous marker and intracorporeal delivery thereof| US7877133B2|2003-05-23|2011-01-25|Senorx, Inc.|Marker or filler forming fluid| US7361183B2|2003-10-17|2008-04-22|Ensure Medical, Inc.|Locator and delivery device and method of use| US8852229B2|2003-10-17|2014-10-07|Cordis Corporation|Locator and closure device and method of use| US20050273002A1|2004-06-04|2005-12-08|Goosen Ryan L|Multi-mode imaging marker| US7653427B2|2004-11-12|2010-01-26|Intra-Medical Imaging LLC|Method and instrument for minimally invasive sentinel lymph node location and biopsy| US8419656B2|2004-11-22|2013-04-16|Bard Peripheral Vascular, Inc.|Post decompression marker introducer system| US8409111B2|2004-11-22|2013-04-02|Bard Peripheral Vascular, Inc.|Removable localizing wire| US8211104B2|2005-01-06|2012-07-03|Boston Scientific Scimed, Inc.|Co-access bipolar ablation probe| US7577473B2|2005-02-03|2009-08-18|Bard Peripheral Vascular, Inc.|Apparatus for subcutaneous placement of an imaging marker| US7635340B2|2005-04-05|2009-12-22|Rubicor Medical, Inc.|Methods and devices for removing tissue from a patient| US10357328B2|2005-04-20|2019-07-23|Bard Peripheral Vascular, Inc. and Bard Shannon Limited|Marking device with retractable cannula| US8926654B2|2005-05-04|2015-01-06|Cordis Corporation|Locator and closure device and method of use| US8088144B2|2005-05-04|2012-01-03|Ensure Medical, Inc.|Locator and closure device and method of use| CA2562580C|2005-10-07|2014-04-29|Inrad, Inc.|Drug-eluting tissue marker| US7896874B2|2005-12-29|2011-03-01|Boston Scientific Scimed, Inc.|RF ablation probes with tine valves| US20070167675A1|2006-01-13|2007-07-19|Olympus Medical Systems Corp.|Overtube and medical procedure via natural orifice using the same| US20070219411A1|2006-01-13|2007-09-20|Olympus Medical Systems Corp.|Overtube and endoscopic treatment system| US20080255422A1|2006-01-13|2008-10-16|Olympus Medical Systems Corp.|Medical device| US8721657B2|2006-01-13|2014-05-13|Olympus Medical Systems Corp.|Medical instrument| US20070167676A1|2006-01-13|2007-07-19|Olympus Medical Systems Corp.|Overtube and medical procedure via natural orifice using the same| US8728121B2|2006-01-13|2014-05-20|Olympus Medical Systems Corp.|Puncture needle and medical procedure using puncture needle that is performed via natural orifice| US7785333B2|2006-02-21|2010-08-31|Olympus Medical Systems Corp.|Overtube and operative procedure via bodily orifice| US8241279B2|2006-02-23|2012-08-14|Olympus Medical Systems Corp.|Overtube and natural opening medical procedures using the same| US20070213702A1|2006-03-08|2007-09-13|Olympus Medical Systems Corp.|Medical procedure carried out via a natural opening| US8016794B2|2006-03-09|2011-09-13|Interrad Medical, Inc.|Anchor device and method| US20090216118A1|2007-07-26|2009-08-27|Senorx, Inc.|Polysaccharide markers| ES2443526T3|2006-10-23|2014-02-19|C.R. Bard, Inc.|Breast marker| EP2109409B1|2006-12-12|2018-09-05|C.R.Bard, Inc.|Multiple imaging mode tissue marker| ES2432572T3|2006-12-18|2013-12-04|C.R. Bard, Inc.|Biopsy marker with imaging properties generated in situ| US20080177258A1|2007-01-18|2008-07-24|Assaf Govari|Catheter with microphone| EP2127697B1|2007-02-21|2012-08-15|National University Corporation Hokkaido University|Dynamic tumor radiation treatment apparatus and dynamic tumor radiation treatment program| US20080221587A1|2007-03-09|2008-09-11|Jeremy Schwartz|Two-stage snare-basket medical device| WO2009079155A2|2007-11-20|2009-06-25|The Cleveland Clinic Foundation|Method and apparatus for tissue sampling| US8311610B2|2008-01-31|2012-11-13|C. R. Bard, Inc.|Biopsy tissue marker| US8038653B2|2008-07-16|2011-10-18|Interrad Medical, Inc.|Anchor systems and methods| US9327061B2|2008-09-23|2016-05-03|Senorx, Inc.|Porous bioabsorbable implant| US9782565B2|2008-10-01|2017-10-10|Covidien Lp|Endoscopic ultrasound-guided biliary access system| US9186128B2|2008-10-01|2015-11-17|Covidien Lp|Needle biopsy device| US9332973B2|2008-10-01|2016-05-10|Covidien Lp|Needle biopsy device with exchangeable needle and integrated needle protection| US8968210B2|2008-10-01|2015-03-03|Covidien LLP|Device for needle biopsy with integrated needle protection| EP3005971A3|2008-12-30|2016-07-20|C.R. Bard, Inc.|Marker delivery device for tissue marker placement| US8328764B2|2009-02-06|2012-12-11|Interrad Medical, Inc.|System for anchoring medical devices| JP4601725B2|2009-02-18|2010-12-22|オリンパスメディカルシステムズ株式会社|Endoscope insertion device| US20100268224A1|2009-04-17|2010-10-21|Trevor Landon|Bipolar electrosurgical tool with active and return electrodes shaped to foster diffuse current flow in the tissue adjacent the return electrode| US8298157B2|2009-12-15|2012-10-30|C. R. Bard, Inc.|Introducer cannula having a tissue anchor for use with a medical instrument| US20110264091A1|2010-04-26|2011-10-27|Rachel Suzanne Koppleman|Apparatus and method for sealing specimen for retrieval| US8758264B2|2011-06-29|2014-06-24|Cook Medical Technologies Llc|Expandable device for full thickness biopsy| USD716450S1|2013-09-24|2014-10-28|C. R. Bard, Inc.|Tissue marker for intracorporeal site identification| USD715942S1|2013-09-24|2014-10-21|C. R. Bard, Inc.|Tissue marker for intracorporeal site identification| USD715442S1|2013-09-24|2014-10-14|C. R. Bard, Inc.|Tissue marker for intracorporeal site identification| USD716451S1|2013-09-24|2014-10-28|C. R. Bard, Inc.|Tissue marker for intracorporeal site identification| WO2018129127A1|2017-01-06|2018-07-12|The Trustees Of The University Of Pennsylvania|Lymph node access needle| WO2019067561A1|2017-09-28|2019-04-04|Merit Medical Systems, Inc.|Biopsy needle sample retention system| WO2021016117A1|2019-07-19|2021-01-28|The Board Of Regents Of The University Of Oklahoma|Endoscope biopsy system and method for ductoscopy|
法律状态:
2000-11-29| AS| Assignment|Owner name: SENORX, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BURBANK, FRED H.;LUBOCK, PAUL;REEL/FRAME:011322/0443 Effective date: 20001127 | 2003-10-09| STCF| Information on status: patent grant|Free format text: PATENTED CASE | 2004-05-25| CC| Certificate of correction| 2007-04-25| FPAY| Fee payment|Year of fee payment: 4 | 2011-03-30| FPAY| Fee payment|Year of fee payment: 8 | 2015-04-15| FPAY| Fee payment|Year of fee payment: 12 |
优先权:
[返回顶部]
申请号 | 申请日 | 专利标题 US7697398P| true| 1998-03-03|1998-03-03|| US09/057,303|US6331166B1|1998-03-03|1998-04-08|Breast biopsy system and method| US09/146,185|US6540693B2|1998-03-03|1998-09-01|Methods and apparatus for securing medical instruments to desired locations in a patients body| US09/159,467|US6261241B1|1998-03-03|1998-09-23|Electrosurgical biopsy device and method| US09/356,187|US6312429B1|1998-09-01|1999-07-16|Electrosurgical lesion location device| US09/477,255|US6471700B1|1998-04-08|2000-01-04|Apparatus and method for accessing biopsy site| US09/727,112|US6638234B2|1998-03-03|2000-11-29|Sentinel node location and biopsy|US09/727,112| US6638234B2|1998-03-03|2000-11-29|Sentinel node location and biopsy| US09/880,218| US6679851B2|1998-09-01|2001-06-12|Tissue accessing and anchoring device and method| PCT/US2001/044265| WO2002043563A2|2000-11-29|2001-11-26|Sentinel node location and biopsy| AU3649002A| AU3649002A|2000-11-29|2001-11-26|Sentinel node location and biopsy| JP2002545550A| JP2004533273A|2000-11-29|2001-11-26|Sentry lymph node localization and biopsy| US10/061,706| US6716179B2|1998-03-03|2002-01-30|Sentinel node location and biopsy| US10/729,086| US7282034B2|1998-09-01|2003-12-05|Tissue accessing and anchoring device and method| US11/112,449| US20050197594A1|1998-09-01|2005-04-21|Tissue accessing and anchoring device and method| 相关专利
Sulfonates, polymers, resist compositions and patterning process
Washing machine
Washing machine
Device for fixture finishing and tension adjusting of membrane
Structure for Equipping Band in a Plane Cathode Ray Tube
Process for preparation of 7 alpha-carboxyl 9, 11-epoxy steroids and intermediates useful therein an
国家/地区
|